BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250219T120000
DTEND;TZID=America/New_York:20250219T130000
DTSTAMP:20260417T085105
CREATED:20250202T223651Z
LAST-MODIFIED:20250202T223651Z
UID:10000554-1739966400-1739970000@ctl.cornell.edu
SUMMARY:Lab to Impact Health Module:   From Discovery to Diagnostics\, Navigating Biomarker Commercialization
DESCRIPTION:Wednesday\, February 19 | 12 – 1 p.m. ET | Virtual  \nInterested in understanding the journey from biomarker discovery to real-world healthcare applications? Researchers and innovators are invited to this insightful discussion on navigating the path from discovery to commercial success in the biomarker and diagnostics space.  \nIndustry leaders and successful entrepreneurs will share practical insights on identifying commercially viable biomarkers\, early-stage validation\, test development\, regulatory pathways\, and integration into clinical practice. Whether you’re considering commercialization or actively developing diagnostic solutions\, this panel offers valuable perspectives on turning promising research into market-ready products.  \nModerated by Iris Bica\, a Business Development and Licensing Associate for the Center of Technology Licensing at Weill Cornell Medicine\, the panel will feature:   \n\nDan Klass\, Senior Director of Emerging Technologies\, Freenome  \n\n\nMarieke Spaan\, Senior Director Corporate Development\, SkylineDx  \n\n\nDaniel Lunz\, CEO & Co-Founder\, Previse \n\nRSVP here
URL:https://ctl.cornell.edu/event/lab-to-impact-health-module-from-discovery-to-diagnostics-navigating-biomarker-commercialization
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2025/02/XPub_Deck_Confidential-e1738535772218.png
END:VEVENT
END:VCALENDAR